We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genus Plc | LSE:GNS | London | Ordinary Share | GB0002074580 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-8.00 | -0.43% | 1,860.00 | 1,860.00 | 1,872.00 | 1,890.00 | 1,830.00 | 1,830.00 | 829,710 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 689.7M | 33.3M | 0.5043 | 37.08 | 1.23B |
TIDMGNS
RNS Number : 4303V
Genus PLC
02 November 2017
FOR IMMEDIATE RELEASE
2 November 2017
Genus plc
Non-Executive Director Retirement
Genus plc (LSE: GNS), a leading global animal genetics company, announces that Duncan Maskell, Non-Executive Director, has informed the Company of his intention to step down from the Genus Board, effective from the 2018 Annual General Meeting. Professor Maskell has served as a Non-Executive Director and advisor to the Company's Research and Development Portfolio Management Team for almost four years and has announced his intention to move to Melbourne, Australia following his appointment as Vice-Chancellor of the University of Melbourne.
Commenting on Professor Maskell's departure, Bob Lawson, Chairman of Genus, said:
"I'm delighted that Duncan is able to continue his work as a Non-Executive Director over the course of the next year, while he settles into his new role at the University of Melbourne. Over the last four years, Duncan has provided the Company with significant scientific expertise, guidance and insight as we progress our innovative platforms in genomics, gene editing and biosystems engineering. We look forward to continuing to work with Duncan over the next year, and wish him the very best in his new role."
For further information please contact:
Genus:
Bob Lawson, Chairman Tel: +44 (0)1256 345970
Karim Bitar, Chief Executive
Buchanan:
Charles Ryland / Vicky Hayns Tel: +44 (0)207 466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAUGGRAGUPMGWP
(END) Dow Jones Newswires
November 02, 2017 10:01 ET (14:01 GMT)
1 Year Genus Chart |
1 Month Genus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions